How China National Accreditation Service (CNAS) Ensures Quality

The China National Accreditation Service for Conformity Assessment (CNAS) is the national accreditation body responsible for ensuring the competence of conformity assessment bodies (CABs) in China. CNAS maintains the quality and reliability of services offered by laboratories, certification bodies, inspection agencies, and verification organisations.

It operates under the authority of the State Administration for Market Regulation (SAMR) and adheres to the Regulations of the People's Republic of China on Certification and Accreditation.

CNAS upholds international accreditation standards and aligns its operations with global conformity assessment frameworks. It is an official member of the International Accreditation Forum (IAF), International Laboratory Accreditation Cooperation (ILAC), and Asia Pacific Accreditation Cooperation (APAC).

History and Evolution of CNAS

CNAS was formally established on March 31, 2006, through the merger of two key accreditation bodies:

• China National Accreditation Board for Certifiers (CNAB) – responsible for accrediting management system certification bodies and product certification bodies.
• China National Accreditation Board for Laboratories (CNAL) – focused on accrediting laboratories and inspection bodies.

The consolidation of these organisations allowed CNAS to streamline accreditation processes and create a unified national accreditation council.

Accreditation of Healthcare and Laboratory Services

For healthcare professionals, CNAS accreditation signifies adherence to stringent quality and safety protocols. In clinical diagnostics, medical device manufacturing, and environmental testing sectors, accreditation is critical for maintaining laboratory integrity, result accuracy, and regulatory compliance.

Accreditation Standards for Healthcare

• ISO 15189 – Medical laboratories’ quality and competence.
• ISO/IEC 17025 – Testing and calibration laboratory accreditation.
• ISO 17020 – Accreditation of inspection bodies.
• ISO 13485 – Quality management for medical device manufacturers.
• ISO/IEC 17021 – Accreditation of management system certification bodies.

To retain their certification, accredited laboratories and organisations must comply with testing accuracy, documentation, and procedural integrity.

CNAS Accreditation Process

The National Association of Testing Authorities in China, represented by CNAS, follows a structured process for accreditation.

1. Application Submission – Organizations submit legal documentation, management system records, and competence assessments.
2. Document Review – CNAS assesses whether the applicant meets ISO and national regulatory standards.
3. On-Site Assessment – Evaluators inspect laboratory procedures, personnel qualifications, and equipment calibration.
4. Decision and Certification – If requirements are met, CNAS grants accreditation.
5. Surveillance and Re-Accreditation – Periodic audits ensure continued compliance.

Why CNAS Accreditation in Healthcare

CNAS accreditation benefits healthcare and life sciences, where testing accuracy, patient safety, and compliance are paramount. The accreditation provides:
1. Recognition of Technical Competence

• CNAS-accredited laboratories demonstrate superior technical capability in testing and calibration.
• Ensures alignment with global healthcare quality standards.

2. Enhanced Customer Trust and Credibility

• Accreditation improves trust in test results, diagnostics, and product evaluations.
• Reduces errors in clinical and medical device testing.

3. Facilitates International Trade and Cooperation

• CNAS accreditation is mutually recognised globally via IAF, ILAC, and APAC agreements.
• Laboratories can collaborate with international partners for cross-border quality assessments.

CNAS and International Mutual Recognition

CNAS participates in IAF Multilateral Recognition Arrangement (MLA) and ILAC Mutual Recognition Arrangement (MRA), allowing international acceptance of test results conducted in CNAS-accredited laboratories. This recognition is crucial for:

• Medical device companies exporting products.
• Clinical laboratories providing international diagnostics.
• Research institutions conducting global collaborations.

This framework minimises duplication of testing efforts and enhances global market access for China-based healthcare entities.

CNAS and the Future of Healthcare Accreditation

With the rapid advancement of digital health technologies, telemedicine, and AI-driven diagnostics, CNAS is adapting its accreditation scope to include emerging areas such as:

• Artificial Intelligence in Healthcare Testing.
• Big data analytics for laboratory assessments.
• Cybersecurity protocols for medical data protection.

As the national accreditation council overseeing these developments, CNAS ensures that healthcare institutions in China remain at the forefront of medical innovation and compliance.

Conclusion

The China National Accreditation Service for Conformity Assessment (CNAS) is essential in ensuring the quality, reliability, and international credibility of conformity assessment services in China. CNAS accreditation is a benchmark for laboratory excellence for healthcare professionals and pathologists– it promotes patient safety, regulatory compliance, and diagnostic accuracy. By maintaining rigorous accreditation standards, CNAS continues to be a pillar of quality assurance in healthcare and beyond.

Related - Role of A2LA in American Laboratory Accreditation